AVIDITY BIOSCIENCES, INC. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e0f75f53-c6b2-4ba7-8a3c-15287f34fd1f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-684.6M | 2025-01-01 – 2025-12-31 | evidence 0001599901-26-000031 |
| FY 2024 | $-322.3M | 2024-01-01 – 2024-12-31 | evidence 0001599901-25-000059 |
| FY 2023 | $-212.2M | 2023-01-01 – 2023-12-31 | evidence 0001599901-24-000025 |
| FY 2022 | $-174.0M | 2022-01-01 – 2022-12-31 | evidence 0001599901-23-000009 |
| FY 2021 | $-118.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-008049 |
| FY 2020 | $-44.4M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013157 |
| FY 2019 | $-24.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-013157 |
| FY 2018 | $-11.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-21-013157 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AVIDITY BIOSCIENCES, INC. — all facts · Revenue · Operating Income